HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna-Leena Sirén Selected Research

Anna-Leena Sirén Research Topics

Disease

6Brain Injuries (Brain Injury)
05/2021 - 02/2006
5Stroke (Strokes)
05/2015 - 08/2002
4Wounds and Injuries (Trauma)
05/2021 - 09/2014
4Traumatic Brain Injuries (Traumatic Brain Injury)
05/2021 - 02/2013
4Inflammation (Inflammations)
01/2017 - 08/2010
4Hypoxia (Hypoxemia)
04/2006 - 07/2002
3Cognitive Dysfunction
05/2021 - 12/2004
3Brain Diseases (Brain Disorder)
10/2009 - 12/2004
2Gliosis
01/2021 - 01/2016
2Closed Head Injuries
01/2016 - 09/2012
2Ischemia
01/2016 - 07/2002
2Ischemic Stroke
05/2015 - 08/2002
2Body Weight (Weight, Body)
07/2014 - 05/2009
2Edema (Dropsy)
04/2012 - 08/2010
2Atrophy
05/2009 - 02/2006
2Schizophrenia (Dementia Praecox)
05/2009 - 12/2004
2Anemia
12/2004 - 08/2004
1Neuroinflammatory Diseases
05/2021
1Thromboinflammation
05/2021
1Brain Ischemia (Cerebral Ischemia)
05/2021
1Medulloblastoma
01/2021
1Neoplasms (Cancer)
01/2021
1Pathologic Processes
01/2017
1Brain Edema (Cerebral Edema)
01/2017
1Thrombosis (Thrombus)
01/2016
1Leukemia
03/2015
1Contusions
09/2014
1Demyelinating Diseases (Demyelinating Disease)
07/2014
1Anhedonia
01/2014
1Phototoxic Dermatitis (Phototoxicity)
07/2013
1Hydrocephalus (Hydrocephaly)
09/2012
1Stiff-Person Syndrome (Stiff Man Syndrome)
11/2010
1Spasm (Spasms)
11/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2010
1Chronic Progressive Multiple Sclerosis
10/2007
1Disease Progression
11/2006
1Spinal Cord Injuries (Spinal Cord Injury)
10/2005
1Cerebral Hemorrhage
10/2004

Drug/Important Bio-Agent (IBA)

8ErythropoietinFDA Link
05/2009 - 08/2002
4Factor XII (Hageman Factor)IBA
05/2021 - 01/2014
4KininsIBA
01/2017 - 08/2010
4Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2004
3Pharmaceutical PreparationsIBA
01/2021 - 08/2002
3Factor XIIa (Coagulation Factor XIIa)IBA
01/2017 - 02/2013
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2009 - 02/2006
2EnzymesIBA
01/2017 - 05/2009
2AutoantibodiesIBA
05/2015 - 11/2010
2Plasma KallikreinIBA
01/2014 - 02/2013
2Bradykinin Receptors (Bradykinin Receptor)IBA
09/2012 - 08/2010
2MelatoninIBA
11/2006 - 10/2002
1Interleukin-1 (Interleukin 1)IBA
05/2021
1Toll-Like Receptor 4IBA
05/2021
1Metalloproteases (Metalloproteinases)IBA
05/2021
1HMGB1 Protein (HMG1)IBA
05/2021
1CytokinesIBA
05/2021
1CorticosteroneIBA
05/2021
1GemcitabineFDA Link
01/2021
1IronIBA
01/2021
1Axitinib (AG 013736)IBA
01/2021
1ImmunosorbentsIBA
01/2017
1BradykininIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1LigandsIBA
01/2017
1CC ChemokinesIBA
01/2017
1Therapeutic UsesIBA
01/2016
1Human Serum AlbuminFDA LinkGeneric
01/2016
1N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
01/2016
1NMDA receptor A1IBA
05/2015
1Apolipoprotein E4IBA
05/2015
1Indicators and Reagents (Reagents)IBA
05/2015
1HLA-G Antigens (HLA G)IBA
03/2015
1Fingolimod Hydrochloride (FTY720)FDA Link
09/2014
1VanadiumIBA
07/2014
1salicylhydroxamic acid (SHAM)IBA
01/2014
1RNA (Ribonucleic Acid)IBA
01/2014
1Sucrose (Saccharose)IBA
01/2014
1KaolinIBA
09/2012
1ChloridesIBA
04/2012
1Evans Blue (Blue, Evans)FDA Link
04/2012
1AntibodiesIBA
11/2010
1amphiphysinIBA
11/2010
1Immunoglobulin G (IgG)IBA
11/2010
1Peptides (Polypeptides)IBA
08/2010
1Neuroprotective AgentsIBA
10/2009
1ParvalbuminsIBA
05/2009
1Cyclic NucleotidesIBA
05/2009
1Myelin ProteinsIBA
05/2009
1gamma-Aminobutyric Acid (GABA)IBA
05/2009
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2009
1Kainic Acid (Kainate)IBA
04/2006
1Glutamic Acid (Glutamate)FDA Link
04/2006
1Dronabinol (THC)FDA LinkGeneric
10/2005
1Estrogens (Estrogen)FDA Link
04/2005
1Estrogen Receptor betaIBA
04/2005
1Hormones (Hormone)IBA
12/2004
1Glycophorins (Glycophorin C)IBA
10/2004

Therapy/Procedure

5Therapeutics
05/2021 - 08/2002
1Ligation
01/2014
1Anesthesia
07/2013
1Intraperitoneal Injections
05/2009